X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 11c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($0.72), $0.11 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Copart (CPRT) Misses Q4 EPS by 4c
• IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance